Published in Hepatitis Weekly, June 14th, 1999
The in vitro effects of amantadine (1-5 microM) and interferon alpha (IFN-(alpha))-2a alone (1,000 IU/ml) and combined, were studied in cultured peripheral blood mononuclear cells (PBMC) from 15 chronic hepatitis C patients and ten healthy donors ("In Vitro Effect of Amantadine and Interferon Alpha-2a on Hepatitis C Virus Markers in Cultured Peripheral Blood Mononuclear Cells from Hepatitis C Virus-Infected Patients," Antiviral Research, May 1999;42(1):59-70).
Amantadine itself did not affect cell viability and had minor effects on the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.